Sernova Biotherapeutics Investor Relations Material
Latest events
AGM 2024
Sernova Biotherapeutics
Q2 2025
12 Jun, 2025
Q1 2025
13 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Sernova Biotherapeutics Inc
Access all reports
Sernova Corp is a biotechnology company focused on developing cell therapy solutions for the treatment of chronic diseases, including diabetes, hemophilia, and thyroid disorders. The company’s lead technology, the Cell Pouch System, is an implantable device designed to house therapeutic cells that can produce essential proteins or hormones, potentially offering a functional cure for diseases such as type 1 diabetes. The company is headquartered in London, Canada, and its shares are listed on the TSX and OTCQB.
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
SVA
Country
🇨🇦 Canada